KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Current Taxes (2016 - 2025)

Eli Lilly (LLY) has disclosed Current Taxes for 17 consecutive years, with $9.4 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Taxes changed N/A year-over-year to $9.4 billion, compared with a TTM value of $9.4 billion through Sep 2025, changed N/A, and an annual FY2024 reading of $1.1 billion, changed N/A over the prior year.
  • Current Taxes was $9.4 billion for Q3 2025 at Eli Lilly, up from $7.0 billion in the prior quarter.
  • Across five years, Current Taxes topped out at $9.4 billion in Q3 2025 and bottomed at $126.6 million in Q2 2022.
  • Average Current Taxes over 5 years is $2.1 billion, with a median of $791.6 million recorded in 2021.
  • The sharpest move saw Current Taxes tumbled 82.66% in 2021, then surged 874.57% in 2023.
  • Year by year, Current Taxes stood at $126.9 million in 2021, then skyrocketed by 274.39% to $475.1 million in 2022, then soared by 316.23% to $2.0 billion in 2023, then tumbled by 43.54% to $1.1 billion in 2024, then surged by 745.97% to $9.4 billion in 2025.
  • Business Quant data shows Current Taxes for LLY at $9.4 billion in Q3 2025, $7.0 billion in Q2 2025, and $6.2 billion in Q1 2025.